Maria Brisbane has been deeply and actively involved with CR&T since joining its board of directors in 2009, dedicating 17 years of distinguished service to this vital mission. Since 1968, CR&T has stood as a world-renowned leader in cancer research, driving groundbreaking advances in the study and treatment of Myeloproliferative Neoplasms as well as other devastating cancers, including pancreatic and bladder cancer. Over nearly six decades, the organization has awarded more than $17 million in research grants, translating scientific discovery into life-saving therapies for patients and families around the world.
Maria Brisbane Cancer Research and Treatment Fund Dinner Gala with Michael Kepner and Steven Loeb
Maria Brisbane has been deeply and actively involved with CR&T since joining its board of directors in 2009, dedicating 17 years of distinguished service to this vital mission. A managing director at Morgan Stanley with more than 25 years of experience in portfolio management for high-net-worth clients, Maria brings exceptional financial acumen to her role on CR&T's Investment Committee, where she helps steward the strategy that sustains the organization's long-term impact. She also served on the Executive Committee for a number of years, providing outstanding leadership that helped guide CR&T's growth and expansion during a pivotal period in its history. Maria has been an integral part of CR&T's Hall of Fame Dinner, a cornerstone annual fundraising event, where her efforts to secure high-profile honorees, including Ouidad and Cokie Roberts, have helped raise millions of dollars in support of cancer research over the years.
Maria Brisbane and Cokie Roberts: Cancer Research and Treatment Fund Dinner